The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

Chronic hepatitis B, caused by persistent infection with HBV, puts >250 million people at risk to develop terminal liver disease. HBV persistence is mediated by an intranuclear, episomal form of the ...

There was no improvement in testing rates over time. Conclusions This study demonstrates that real-life testing uptake for viral hepatitis B and C is suboptimal in the general practices in Flanders, ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

Molecular diagnosis of HAV along with anti-HAV IgG avidity measurement are helpful in case of positive IgM where laboratory evidence of acute hepatitis is absent and there is no epidemiologic link ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

The immunological mechanisms of mAb-mediated viral clearance were systematically investigated. Results Among 11 tested mAbs, a novel mAb E6F6 exhibited the most striking therapeutic effects in several ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

Background Hepatitis B virus (HBV) is a common cause of viral hepatitis with significant health complications including cirrhosis and hepatocellular carcinoma. Assays for hepatitis B surface ...

Collaboration with South Korean university advocates early antiviral treatment for hepatitis B | Feb. 5, 2025 13:09 ...

Infection with hepatitis D viruses causes severe inflammation of the liver. An MHH team has now identified a marker on natural killer cells that is influenced by the anti-inflammatory effectiveness of ...

If no other government comes forward to close the funding gap, we will face an alarming increase in transmission,' says Finn Jarle Rode, executive director of The Hepatitis Fund - Anadolu Ajansı ...